Trials / Conditions / Subfoveal Choroidal Neovascularization
Subfoveal Choroidal Neovascularization
3 registered clinical trials studyying Subfoveal Choroidal Neovascularization.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD NCT02599064 | RXi Pharmaceuticals, Corp. | Phase 1 / Phase 2 |
| Terminated | Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascul NCT01122511 | Allergan | Phase 2 |
| Withdrawn | Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And R NCT00930189 | Asociación para Evitar la Ceguera en México | Phase 2 / Phase 3 |